Real-world cost analysis of intravitreal aflibercept 8 mg versus 2 mg in retinal disease treatment

Meltem Yashar, Catherine Yao, Luqman Munir, Felipe Barandiaran, Anupam K Garg, Yannis M Paulus

Open source

DOI: 10.1136/bjo-2026-330093
Published: 2026-11-03
Container: British Journal of Ophthalmology
Publisher: BMJ
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bjo-2026-330093,
  title = {Real-world cost analysis of intravitreal aflibercept 8 mg versus 2 mg in retinal disease treatment},
  author = {Meltem Yashar and Catherine Yao and Luqman Munir and Felipe Barandiaran and Anupam K Garg and Yannis M Paulus},
  year = {2026},
  journal = {British Journal of Ophthalmology},
  doi = {10.1136/bjo-2026-330093},
  url = {https://doi.org/10.1136/bjo-2026-330093}
}

RIS

TY  - JOUR
TI  - Real-world cost analysis of intravitreal aflibercept 8 mg versus 2 mg in retinal disease treatment
AU  - Meltem Yashar
AU  - Catherine Yao
AU  - Luqman Munir
AU  - Felipe Barandiaran
AU  - Anupam K Garg
AU  - Yannis M Paulus
PY  - 2026
JO  - British Journal of Ophthalmology
DO  - 10.1136/bjo-2026-330093
UR  - https://doi.org/10.1136/bjo-2026-330093
ER  -

APA

Yashar, M., Yao, C., Munir, L., Barandiaran, F., Garg, A. K., & Paulus, Y. M. (2026). Real-world cost analysis of intravitreal aflibercept 8 mg versus 2 mg in retinal disease treatment. British Journal of Ophthalmology. https://doi.org/10.1136/bjo-2026-330093

Source records

crossref · retrieved 2026-11-10T13:41:16.668Z